Australia Peptide And Oligonucleotide Cdmo Market Size & Outlook

Name: Australia Peptide And Oligonucleotide Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The peptide and oligonucleotide cdmo market in Australia is expected to reach a projected revenue of US$ 206.2 million by 2033. A compound annual growth rate of 13.8% is expected of Australia peptide and oligonucleotide cdmo market from 2025 to 2033.

Australia peptide and oligonucleotide cdmo product outlook (Revenue, USD million, 2021-2033)
- Peptides
- Oligonucleotides
Australia peptide and oligonucleotide cdmo service type outlook (Revenue, USD million, 2021-2033)
- Contract Development
- Contract Manufacturing
Australia peptide and oligonucleotide cdmo end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others

Australia Peptide And Oligonucleotide Cdmo Market Size & Outlook

Sign up - it's easy, and free!